PITPNA and renal carcinoma: PITPNA which we found as a good prognostic indicator, is suggested as favorable prognostic marker in pancreatic, endometrial and renal cancers in the Human Protein Atlas (www.proteinatlas.org) [68], and its overexpression was associated with longer survival in PDAC [69].